SandoSTATIN LAR 20 MG Injection
- RxCUI
- 898591
- RxNorm name
- SandoSTATIN LAR 20 MG Injection
- Display name
- SandoSTATIN LAR 20 MG Injection
- Full name
- SandoSTATIN LAR 20 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sandostatin LAR Depot | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | 2025-12-22 | Warnings, Adverse reactions | 898591 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | SandoSTATIN LAR 20 MG Injection | PSN | 29 | These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | 20251222 |
| d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | Sandostatin 20 MG Injection | SY | 29 | These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | 20251222 |
| d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | octreotide 20 MG Injection [Sandostatin] | SBD | 29 | These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988 | 20251222 |